| ACRS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ACRS shares outstanding history going back to 10/7/2015:
Also see: ACRS Market Cap History ACRS YTD Return |
ACRS Shares Outstanding History — Aclaris Therapeutics Share Count Over Time
As of 4/30/2026 Aclaris Therapeutics has 139.66 million ACRS shares outstanding. Investors often track the ACRS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ACRS share count trends over time, with 44 historical shares outstanding datapoints presented, dating back to 10/7/2015.
| ACRS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ACRS Historical Shares Outstanding: +20.53% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACRS Stock Price Chart |
| About Aclaris Therapeutics Inc |
| Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. Co. has a multi-stage portfolio of drug candidates powered by a robust research and development engine exploring protein kinase regulation. Its segments include therapeutics and contract research. The therapeutics segment is focused on identifying and developing therapies to address unmet needs for immuno-inflammatory diseases and providing licensing of its intellectual property. The contract research segment provides laboratory services. We show 44 historical shares outstanding datapoints in our coverage of ACRS's shares outstanding history. Understanding the changing numbers of ACRS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACRS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACRS by allowing them to research ACRS shares outstanding history as well as any other stock in our coverage universe. |
| ACRS Current Stock Quote |
Quotes delayed 20 minutes  Free ACRS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ACRS Share Performance |
| Shares Outstanding Peers |
| Aclaris Therapeutics (ACRS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ACRV Shares Outstanding History ACRX Shares Outstanding History ACST Shares Outstanding History ACTU Shares Outstanding History ACXP Shares Outstanding History ADGI Shares Outstanding History ADIL Shares Outstanding History ADMA Shares Outstanding History ADMP Shares Outstanding History ADMS Shares Outstanding History More Healthcare companies » |
ACRS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
